Corline Biomedical AB (STO:CLBIO)
Sweden · Delayed Price · Currency is SEK 18.20
-0.25 (-1.36%)
Aug 13, 2026, 5:09 PM CET
Corline Biomedical AB Market Cap
Corline Biomedical AB has a market cap or net worth of 482.16 million as of August 13, 2026. Its market cap has increased by 51.44% in one year.
Market Cap
482.16M
Enterprise Value
454.51M
Revenue
10.67M
Ranking
n/a
PE Ratio
n/a
Stock Price
18.20
ChartMarket Cap Chart
Since June 3, 2015, Corline Biomedical AB's market cap has increased from 97.97M to 482.16M, an increase of 392.17%. That is a compound annual growth rate of 15.29%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2026 | 482.16M | 36.80% |
| Dec 30, 2025 | 352.45M | 86.79% |
| Dec 30, 2024 | 188.69M | -41.07% |
| Dec 29, 2023 | 320.21M | 61.61% |
| Dec 30, 2022 | 198.15M | -36.85% |
| Dec 30, 2021 | 313.77M | 25.86% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AlzeCure Pharma AB | 926.67M |
| Infant Bacterial Therapeutics AB | 875.64M |
| Xspray Pharma AB | 679.95M |
| Oncopeptides AB | 628.51M |
| FluoGuide | 510.10M |
| Cantargia AB | 454.96M |
| Mendus AB | 428.27M |
| Intervacc AB | 411.70M |